Nonprofit · EIN 23-7033369
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION
Tax-exempt · BETHESDA, MD 20814
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| May 31, 2025 | 990 | $3,585,475 | $3,245,282 | $340,193 | $14,275,101 | $673,342 | $13,601,759 |
| May 31, 2024 | 990 | $2,985,544 | $3,370,175 | -$384,631 | $13,572,570 | $724,192 | $12,848,378 |
| May 31, 2023 | 990 | $3,278,745 | $2,993,667 | $285,078 | $12,995,656 | $811,149 | $12,184,507 |
Financial details: 990 for the year ended May 31, 2025
Revenue
- Contributions, gifts and grants
- $1,714,721
- Program service revenue
- $1,199,097
- Investment income
- $671,657
- Net gain from sales of assets
- $143,805
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $730,281
- Compensation of officers, directors and key employees
- $1,121,931
- Other salaries and wages
- $518,295
- Salaries, compensation and benefits (total)
- $1,787,502
- Professional fundraising fees
- $0
- Accounting fees
- $13,750
- Travel
- $156,186
- Depreciation
- $29,977
- Program services (functional)
- $2,103,974
- Management and general (functional)
- $364,982
- Fundraising (functional)
- $776,326
Balance sheet and other
- Total assets, start of year
- $13,572,570
- Total assets, end of year
- $14,275,101
- Total liabilities, end of year
- $673,342
- Net assets, end of year
- $13,601,759
- Land, buildings and equipment
- $10,394
- Publicly traded securities
- $13,277,956
- Net assets without donor restrictions
- $4,457,187
- Net assets with donor restrictions
- $9,144,572
- Gross receipts
- $4,445,044
- Employees
- 0
- Volunteers
- 100
- Year formed
- 1968
- State of legal domicile
- MD
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended May 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| PAUL W ABRAMOWITZ | PRESIDENT Trustee or director, Officer | 2 | $0 | $1,165,359 | $65,673 |
| STEVEN A RUBLOFF | SECRETARY AND CEO Former | 40 | $242,866 | $0 | $46,353 |
| BARBARA NUSSBAUM | VP, RESEARCH AND EDUCATION Highest-paid employee | 40 | $206,516 | $0 | $56,945 |
| KELLY MCCORMICK-SULLIVAN | SECRETARY AND CEO Trustee or director, Officer | 40 | $185,739 | $0 | $21,334 |
| MARTHA CREWS | VP, DEVELOPMENT Highest-paid employee | 40 | $148,601 | $0 | $50,167 |
| STEPHANIE BROWN | SENIOR DIRECTOR, OPERATIONS Highest-paid employee | 40 | $134,570 | $0 | $28,842 |
| NISHAMINY KASBEKAR | IMMEDIATE PAST PRESIDENT OF ASHP Trustee or director | 1 | $0 | $10,000 | $0 |
| LEIGH BRISCOE-DWYER | PRESIDENT OF ASHP Trustee or director | 1 | $0 | $10,000 | $0 |
| WENDY HORTON | DIRECTOR AT LARGE Trustee or director | 1 | $0 | $800 | $0 |
| KELLY M SMITH | CHAIR Trustee or director, Officer | 1 | $0 | $0 | $0 |
| KEN PEREZ | VICE CHAIR Trustee or director, Officer | 1 | $0 | $0 | $0 |
| CHRISTENE JOLOWSKY | TREASURER Trustee or director, Officer | 1 | $0 | $0 | $0 |
| ROGER ANDERSON | DIRECTOR AT LARGE Trustee or director | 1 | $0 | $0 | $0 |
| CHRIS HATWIG | DIRECTOR AT LARGE Trustee or director | 1 | $0 | $0 | $0 |
| ELLEN MENARD | DIRECTOR AT LARGE Trustee or director | 1 | $0 | $0 | $0 |
4 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| THOMAS J RICE | DIRECTOR AT LARGE Trustee or director | 1 | $0 |
| SCOTT M SAMSON | DIRECTOR AT LARGE Trustee or director | 1 | $0 |
| LINDSEY THOMAS | DIRECTOR AT LARGE Trustee or director | 1 | $0 |
| JON ZWINSKI | DIRECTOR AT LARGE Trustee or director | 1 | $0 |
990 for the year ended May 31, 2024: 19 people
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| PAUL W ABRAMOWITZ | PRESIDENT Trustee or director, Officer | 2 | $0 | $1,108,782 | $63,928 |
| STEVEN A RUBLOFF | SECRETARY AND CEO Trustee or director, Officer | 40 | $363,803 | $0 | $73,111 |
| BARBARA NUSSBAUM | VP, RESEARCH AND EDUCATION Highest-paid employee | 40 | $202,394 | $0 | $59,825 |
| MARTHA CREWS | VP, DEVELOPMENT Highest-paid employee | 40 | $151,396 | $0 | $48,455 |
| STEPHANIE BROWN | DIRECTOR, OPERATIONS Highest-paid employee | 40 | $132,788 | $0 | $28,509 |
| PAUL C WALKER | IMMEDIATE PAST PRESIDENT OF ASHP Trustee or director | 1 | $0 | $10,000 | $0 |
| NISHAMINY KASBEKAR | PRESIDENT OF ASHP Trustee or director | 1 | $0 | $10,000 | $0 |
| LEIGH BRISCOE-DWYER | PRESIDENT-ELECT OF ASHP Trustee or director | 1 | $0 | $10,000 | $0 |
| KELLY M SMITH | CHAIR Trustee or director, Officer | 1 | $0 | $0 | $0 |
| KEN PEREZ | VICE CHAIR Trustee or director, Officer | 1 | $0 | $0 | $0 |
| CHRISTENE JOLOWSKY | TREASURER Trustee or director, Officer | 1 | $0 | $0 | $0 |
| ROGER ANDERSON | DIRECTOR AT LARGE Trustee or director | 1 | $0 | $0 | $0 |
| CHRIS HATWIG | DIRECTOR AT LARGE Trustee or director | 1 | $0 | $0 | $0 |
| WENDY HORTON | DIRECTOR AT LARGE Trustee or director | 1 | $0 | $0 | $0 |
| ELLEN MENARD | DIRECTOR AT LARGE Trustee or director | 1 | $0 | $0 | $0 |
| THOMAS J RICE | DIRECTOR AT LARGE Trustee or director | 1 | $0 | $0 | $0 |
| SCOTT M SAMSON | DIRECTOR AT LARGE Trustee or director | 1 | $0 | $0 | $0 |
| LINDSEY THOMAS | DIRECTOR AT LARGE Trustee or director | 1 | $0 | $0 | $0 |
| JON ZWINSKI | DIRECTOR AT LARGE Trustee or director | 1 | $0 | $0 | $0 |
990 for the year ended May 31, 2023: 17 people
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| PAUL W ABRAMOWITZ | PRESIDENT Trustee or director, Officer | 3 | $0 | $1,056,203 | $62,392 |
| STEVEN A RUBLOFF | SECRETARY AND CEO Trustee or director, Officer | 40 | $375,648 | $0 | $71,543 |
| BARBARA NUSSBAUM | VP, RESEARCH AND EDUCATION Highest-paid employee | 40 | $194,806 | $0 | $62,519 |
| MARTHA CREWS | VP, DEVELOPMENT Highest-paid employee | 40 | $139,571 | $0 | $48,033 |
| STEPHANIE BROWN | DIRECTOR, OPERATIONS Highest-paid employee | 40 | $129,291 | $0 | $27,155 |
| LINDA S TYLER | IMMEDIATE PAST PRESIDENT OF ASHP Trustee or director | 1 | $0 | $10,500 | $0 |
| PAUL C WALKER | PRESIDENT OF ASHP Trustee or director | 1 | $0 | $10,000 | $0 |
| CHRIS HATWIG | DIRECTOR AT LARGE Trustee or director | 1 | $0 | $0 | $0 |
| CHRISTENE JOLOWSKY | TREASURER Trustee or director, Officer | 1 | $0 | $0 | $0 |
| ELLEN WETTERLING | DIRECTOR AT LARGE Trustee or director | 1 | $0 | $0 | $0 |
| KELLY M SMITH | CHAIR Trustee or director, Officer | 1 | $0 | $0 | $0 |
| KEN PEREZ | VICE CHAIR Trustee or director, Officer | 1 | $0 | $0 | $0 |
| LINDSEY THOMAS | DIRECTOR AT LARGE Trustee or director | 1 | $0 | $0 | $0 |
| ROGER ANDERSON | DIRECTOR AT LARGE Trustee or director | 1 | $0 | $0 | $0 |
| SCOTT M SAMSON | DIRECTOR AT LARGE Trustee or director | 1 | $0 | $0 | $0 |
| THOMAS J RICE | DIRECTOR AT LARGE Trustee or director | 1 | $0 | $0 | $0 |
| WENDY HORTON | DIRECTOR AT LARGE Trustee or director | 1 | $0 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 4500 EAST WEST HWY STE 900, BETHESDA, MD 20814-3417
- Principal officer (990 for 2024)
- KELLY MCCORMICK-SULLIVAN, 4500 EAST-WEST HIGHWAY 900, BETHESDA, MD 20814
- Signed the 990
- KELLY MCCORMICK-SULLIVAN, CHIEF EXECUTIVE OFFICER
- Phone
- (301) 664-8612
- Website
- WWW.ASHPFOUNDATION.ORG
- Return prepared by
- APRIO ADVISORY GROUP LLC
Mission
OUR MISSION: SUPPORT ASHP BY ADVANCING THE PROFESSIONAL PRACTICE OF PHARMACISTS AND THE PHARMACY WORKFORCE BY FUNDING RESEARCH AND EDUCATION THAT IMPROVES HEALTH OUTCOMES THROUGH OPTIMAL, SAFE, AND EFFECTIVE MEDICATION USE.
Program accomplishments
- EXCELLENCE IN PHARMACY PRACTICE AND LEADERSHIP DEVELOPMENT: RECOGNIZE AND PROMOTE EFFORTS THAT FOSTER EXCELLENCE AND GROWTH OF HEALTH-SYSTEM PHARMACY. ASHP STUDENT LEADERSHIP AWARD: THIS PROGRAM, FUNDED THROUGH THE DAVID A. ZILZ FUND, IS ADMINISTERED BY THE ASHP PHARMACY STUDENT FORUM IN COLLABORATION WITH THE ASHP FOUNDATION. TWELVE STUDENTS WHO DEMONSTRATED HIGH ACADEMIC ACHIEVEMENT, EXCEPTIONAL INTEREST IN HEALTH-SYSTEM PHARMACY PRACTICE, AND OUTSTANDING LEADERSHIP SKILLS WERE RECOGNIZED. THE AWARDEES RECEIVED A PLAQUE, A $2,000 AWARD AND AN ASHP DRUG INFORMATION LIBRARY. EACH AWARDEE SUBMITTED A PLAN TO RAISE STUDENT AWARENESS OF THE ASHP PRACTICE ADVANCEMENT INITIATIVE. AWARDEES WILL BE SURVEYED TO COLLECT INFORMATION ON THE IMPLEMENTATION AND OUTCOMES OF THEIR PLAN.PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM: SAMSON MEDICAL TECHNOLOGIES AND MEDI-DOSE SUPPORTED THE 2024 PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM. THIS UNIQUE AWARD RECOGNIZES EXCELLENCE AND LEADERSHIP IN THE TRAINING AND MENTORING OF PHARMACY RESIDENTS. THE PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM RECOGNIZES A PRECEPTOR, NEW PRECEPTOR AND PROGRAM. THE OBJECTIVES OF THIS PROGRAM ARE TO: 1) RECOGNIZE THE ACHIEVEMENTS OF RESIDENCY PROGRAMS AND PHARMACISTS WHO HAVE DEMONSTRATED EXCELLENCE AND LEADERSHIP IN THE TRAINING OF PHARMACY RESIDENTS AND 2) WIDELY DISSEMINATE THE RESULTS OF THESE ACCOMPLISHMENTS TO FOSTER INNOVATIONS IN PHARMACY RESIDENT TRAINING. AWARDEES RECEIVE A PLAQUE AND PARTICIPATE IN SHORT INTERVIEWS AND ARE RECOGNIZED THROUGH VARIOUS ELECTRONIC PLATFORMS AND AT THE ASHP MIDYEAR CLINICAL MEETING AND EXHIBITION (ASHP MIDYEAR). EACH AWARDEE WILL ALSO PRESENT AN EDUCATIONAL WEBINAR ON RESIDENT PROFESSIONAL DEVELOPMENT TOPICS. THE WEBINARS ARE RECORDED AND MADE AVAILABLE FOR ON-DEMAND ACCESS. LITERATURE AWARDS PROGRAM: THE ASHP FOUNDATION LITERATURE AWARDS PROGRAM RECOGNIZES IMPORTANT CONTRIBUTIONS TO BIOMEDICAL LITERATURE BY PHARMACISTS. THIS PROGRAM, ADMINISTERED BY THE ASHP FOUNDATION SINCE 1971, RECOGNIZES TO STIMULATE INNOVATION AND FOSTERS IMPROVEMENT IN THE QUALITY OF THE EVIDENCE. AWARDEES WERE RECOGNIZED IN FIVE (5) DIFFERENT CATEGORIES IN 2024. AWARDEES RECEIVE AN HONORARIUM, PLAQUE, PARTICIPATE IN SHORT INTERVIEWS AND PODCASTS, AND ARE RECOGNIZED THROUGH VARIOUS ELECTRONIC PLATFORMS AND AT THE ASHP MIDYEAR MEETING. MIDYEAR TRAVEL AWARD: THE MIDYEAR TRAVEL AWARD, ORIGINALLY CREATED AS A COLLABORATION BETWEEN THE ASHP FOUNDATION AND #PHARMGRADWISHLIST, AWARDED 32 PHARMD CANDIDATES WITH A $500 TRAVEL STIPEND, REGISTRATION TO THE ASHP MIDYEAR MEETING, AND A ONE-YEAR ASHP MEMBERSHIP. THERE WERE 260 APPLICATIONS RECEIVED FOR THE AWARD IN FY25. THE PROGRAM WAS PARTIALLY FUNDED VIA $25,000 DONATIONS EACH FROM MARVIN SAMSON AND APEXUS, ALONG WITH INDIVIDUAL DONATIONS. ASHP FOUNDATION PHARMACY STUDENT SCHOLARSHIP: IN FY25, THE ASHP FOUNDATION ENGAGED WITH SELECTED RECIPIENTS OF THE PHARMACY STUDENT SCHOLARSHIP. THE SCHOLARSHIP WAS AWARDED IN SPRING 2025 (FY24) THROUGH FOUR US-ACCREDITED HISTORICALLY BLACK COLLEGES AND UNIVERSITIES (HBCUS) SCHOOLS OF PHARMACY FOR THE 2024-2025 ACADEMIC YEAR. NO SCHOLARSHIPS WERE AWARDED THROUGH THIS PROGRAM IN FY25. PHARMACIST NUTRITION SUPPORT PATIENT-CARE IMPACT PROGRAM: SUPPORTED BY AN EDUCATIONAL GRANT FROM BAXTER AND OFFERED IN COLLABORATION WITH ASHP'S SECTION ON CLINICAL SPECIALISTS AND SCIENTISTS, THE PHARMACIST NUTRITION SUPPORT PATIENT-CARE IMPACT PROGRAM DISTANCE PROGRAM IS DESIGNED TO DEVELOP LEADERS WITH KNOWLEDGE AND SKILLS TO OPTIMIZE SAFE AND EFFECTIVE NUTRITIONAL SUPPORT NEEDS OF PATIENTS. A COHORT OF EIGHT PHARMACY RESIDENTS IN PGY2 PROGRAMS WERE SELECTED TO COMPLETE THE PROGRAM WITH THEIR PRECEPTOR. THE PREVIOUS COHORT COMPLETED THE EXPERIENTIAL PORTION OF THE PROGRAM THROUGHOUT FY25. THE APPLICATION FOR A NEW CYCLE OPENED IN FY25, WITH THE COHORT SELECTED IN FY26. MEDICATION SAFETY SCHOLARS: ASHP FOUNDATION IN PARTNERSHIP WITH EMILY JERRY FOUNDATION AND THE ASHP STUDENT FORUM SELECTED PARTICIPANTS FOR THE MEDICATION SAFETY SCHOLARS PROGRAM. THE COHORT PARTICIPATED IN A DISTANCE IMPACT PROGRAM STRUCTURED TO SUPPORT FIVE P2 AND P3 DOCTOR OF PHARMACY STUDENTS, PAIRED WITH ONE GROUP COACH, TO ENHANCE THEIR KNOWLEDGE AND SKILLS IN MEDICATION SAFETY. THE COHORT WILL HAVE A NETWORKING DINNER AND FINALIZE THEIR PROJECT IN FY26. PHARMACY RESIDENCY EXPANSION GRANT: IN FY25, SUPPORTED BY AN EDUCATIONAL DONATION FROM MERCK & CO., INC., RAHWAY, NJ, USA, THE ASHP FOUNDATION AWARDED A TOTAL OF $75,000 DOLLARS IN GRANTS TO THREE (3) PGY-1 AND PGY-2 PHARMACY RESIDENCY PROGRAMS TO INCREASE THE NUMBER OF AVAILABLE TRAINING POSITIONS. PHARMACY STUDENT CLINICAL SKILLS COMPETITION: GABRIELLA MIGNOSA AND EMMA VAN REYSEN FROM THE UNIVERSITY OF RHODE ISLAND COLLEGE OF PHARMACY COMPETED FOR THE 2024 ASHP NATIONAL CLINICAL SKILLS COMPETITION, AND WON THE COMPETITION IN DECEMBER 2024, DURING THE ASHP MIDYEAR CLINICAL MEETING IN NEW ORLEANS, LA. THE FOUNDATION HAS SPONSORED THE PHARMACY STUDENT CLINICAL SKILLS COMPETITION (CSC) AT THE ASHP MIDYEAR CLINICAL MEETING FOR 19 YEARS. TEAMS WHO WON PRELIMINARY COMPETITIONS AT THEIR LOCAL PHARMACY SCHOOL PARTICIPATED IN THE COMPETITION. DURING THE CSC, STUDENTS DEMONSTRATE THEIR SKILLS BY ASSESSING PATIENT INFORMATION AND CURRENT THERAPY, IDENTIFYING AND PRIORITIZING DRUG THERAPY PROBLEMS, IDENTIFYING TREATMENT GOALS, AND RECOMMENDING A PHARMACIST CARE PLAN.EXCELLENCE IN RESIDENCY: FUNDED THROUGH THE DANIEL M. ASHBY FUND FOR EXCELLENCE IN PHARMACY RESIDENCY TRAINING, THE FOUNDATION CONTRACTED WITH UNIVERSITY OF GEORGIA (UGA) AND ASHP'S ACCREDITATION SERVICES DIVISION ON A GRANT TO UGA AND SUBSEQUENT RESEARCH PROJECT TO STUDY RESIDENTS' PROGRAM EXPERIENCES AND COMPLETION. PHARMACY LEADERSHIP ACADEMY (PLA): THE PLA, SUPPORTED IN PART BY A DONATION FROM APEXUS, IS AN ONLINE EDUCATION PROGRAM DESIGNED TO PROVIDE COMPREHENSIVE LEADERSHIP EDUCATION TO PHARMACISTS AND PHARMACY TECHNICIANS. THE PLA CLASS IN FY25 CONSISTED OF 104 PARTICIPANTS, WHO ALSO REMITTED TUITION AND WERE ENROLLED IN THE PROGRAM FROM JULY 2024 TO JUNE 2025. THE NUMBER OF GRADUATES FROM THIS CLASS BRINGS THE TOTAL NUMBER OF PLA GRADUATES ALMOST 1,400.WILLIAM A. ZELLMER LEADERSHIP LECTURE: WHERE PRACTICE MEETS POLICY:THIS ANNUAL LUNCHEON-LECTURE EVENT, HOSTED BY ASHP IN PARTNERSHIP WITH THE ASHP FOUNDATION, IS DESIGNED TO HONOR THE DISTINGUISHED 40-YEAR ASHP CAREER OF WILLIAM A. ZELLMER AND IS SUPPORTED BY DONORS TO THE ASHP FOUNDATION'S WILLIAM ZELLMER FUND. COL. WILLIAM MICHAEL HEATH, MBA PRESENTED THE LECTURE ON SEPTEMBER 17, 2024, DURING ASHP'S ANNUAL POLICY WEEK ACTIVITIES. JOSEPH A. ODDIS ETHICS COLLOQUIUM:THE JOSEPH A. ODDIS ETHICS COLLOQUIUM FOCUSED ON THE TOPICS: ETHICAL DIMENSION OF ARTIFICIAL INTELLIGENCE (AI) IN PHARMACY. THE SESSION WAS PLANNED AND LED BY THE PROGRAM CHAIR IN JUNE DURING THE 2024 ASHP PHARMACY FUTURES MEETING IN PORTLAND, OR.STRATEGIC EXECUTION PROJECT:SUPPORTED BY A DONATION FROM OMNICELL, INC. AND FUNDS FROM THE DAVID A. ZILZ LEADERS FOR THE FUTURE FUND AND MARIANNE F. IVEY FUND FOR PHARMACY LEADERSHIP DEVELOPMENT, A SURVEY PROJECT WAS LAUNCHED TO EXPLORE THE CURRENT STATE OF STRATEGIC PLANNING AND EXECUTION. A GOAL OF THE PROJECT IS TO PREPARE TOMORROW'S GENERATION OF PHARMACY LEADERS, BY UNDERSTANDING HOW THE LEADERS OF TODAY OPERATE THROUGH A SURVEY AND ANALYSIS OF THE RESULTS. HEALTH SYSTEM PHARMACY LEADERS WERE RECRUITED TO ADVISE ON THE DEVELOPMENT OF THE SURVEY AND ANALYSIS OF THE RESULTS. A MANUSCRIPT OF THE SURVEY RESULTS WAS SUBMITTED TO AJHP IN OCTOBER 2025. PLANNED FOR SPRING 2026 IS A RESULTS OVERVIEW INFOGRAPHIC AND A VIRTUAL NETWORKING SESSION TO ENGAGE LEADERS IN THE RESULTS AND PLANNING FUTURE ACTIVITIES.ASHP NATIONAL PUBLIC AWARENESS CAMPAIGN: THIS GRANT TO ASHP WAS PROVIDED TO SUPPORT THE DEVELOPMENT AND IMPLEMENTATION OF THE ASHP NATIONAL PUBLIC AWARENESS CAMPAIGN. THE GOAL OF THE PROJECT IS TO HAVE A COMPREHENSIVE NATIONAL AWARENESS CAMPAIGN TO BRING VISIBILITY AND RECOGNITION TO THE CRITICAL AND DIVERSE ROLES OF PHARMACISTS AND PHARMACY TECHNICIANS IN HOSPITALS AND HEALTH SYSTEMS.VISITING LEADERS PROGRAM (VLP): THE VISITING LEADERS PROGRAM, WITH SUPPORT FROM THE SARA J. WHITE LEADERSHIP FUND AND DAVID A. ZILZ LEADERS FOR THE FUTURE FUND, HAD ANOTHER SUCCESSFUL YEAR. NINE LEADERS WERE INVOLVED IN 16 RESIDENCY VISITS TO DISCUSS EMERGING LEADERSHIP TOPICS WITH PHARMACY RESIDENTS AND PRECEPTORS. SPECIALTY PHARMACY SURVEY:ASHP FOUNDATION PROVIDED THE REMAINING FUNDING OF $10,000 GRANTS TO ASHP FOR THE SPECIALTY PHARMACY SURVEY. THE INITIAL FUNDING WAS GRANTED IN FY24.Expenses $1,268,696 · grants $432,392 · revenue $1,164,097
- INNOVATIVE RESEARCH: SUPPORT HEALTH SERVICES RESEARCH THAT FOSTER INNOVATION IN PHARMACY PRACTICE, WHICH PROMOTES THE OPTIMAL, SAFE AND EFFECTIVE USE OF MEDICATION.AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION (AFPE) PRE-DOCTORAL FELLOWSHIP: THE ASHP FOUNDATION PROVIDED ANNUAL FUNDING OF $10,000 FOR THE AFPE PRE-DOCTORAL FELLOWSHIP PROGRAM AWARDED TO PH.D. STUDENTS WHOSE RESEARCH PROJECTS FOCUS ON IMPROVING HEALTH OUTCOMES IN HOSPITALS, HEALTH SYSTEMS, AND AMBULATORY CARE CLINICS. RADIO FREQUENCY IDENTIFICATION (RFID) INITIATIVE: IN ALIGNMENT WITH THE ASHP INNOVATION CENTER AND THROUGH SUPPORT FROM FRESENIUS KABI, THE ASHP FOUNDATION CONTINUED TO WORK ON THE NEXT PHASES OF THE RFID INITIATIVE. IN SEPTEMBER AND NOVEMBER 2024, VIRTUAL ENGAGEMENT SESSIONS WERE CONDUCTED WITH FACILITATION AND BREAKOUT SESSIONS. THE SESSIONS HIGHLIGHTED IMPLEMENTED RFID USE-CASE, RECOMMENDATIONS, AND OUTCOMES. ADDITIONALLY, FUNDING FOR A NEW RESEARCH PROJECT HAS BEEN SECURED. PHARMACY LEADERSHIP SCHOLARS:WITH CORPORATE SUPPORT FROM CHIESI, A NEW CYCLE OF THE PHARMACY LEADERSHIP SCHOLARS PROGRAM WAS LAUNCHED. THE RESEARCH GRANT PROGRAM PROVIDES FUNDING FOR PROJECTS FOCUSED ON ACCESS TO CARE, CONDUCTED BY EARLY-STAGE PHARMACISTS. IN ADDITION TO PROVIDING UP TO $10,000 IN GRANT FUNDING PER RECIPIENT, THE PROGRAM'S GOAL IS TO ENHANCE THE LEADERSHIP AND RESEARCH SKILLS OF RECIPIENTS AND TO PROVIDE A NETWORK OF PHARMACISTS POSITIONED TO LEAD. FOUR PROJECTS WERE FUNDED IN FY25 AND GRANTEES PARTICIPATED IN FOUR MODULES, LED BY FACULTY, AND ENGAGED IN LIVE DISCUSSION CALLS WITH FACULTY AND A COACH. ADDITIONALLY, THE APPLICATION PROCESS FOR A NEW CYCLE WAS COMPLETED AND GRANTEES SELECTED TO PARTICIPATE IN THE PROGRAM IN FY26. COLLABORATIVE CARE GRANT FOR NURSES AND PHARMACISTS:CREATED IN PARTNERSHIP BY THE ASHP FOUNDATION AND THE AMERICAN NURSES FOUNDATION, THIS GRANT PROGRAM AIMS TO STIMULATE PATIENT-CENTERED INTERPROFESSIONAL HEALTH SERVICES RESEARCH THAT DEMONSTRATES MEANINGFUL OUTCOMES AND PROVIDES FUNDING OF $75,000. THE FINAL PAYMENT FOR THE PREVIOUS CYCLE'S GRANTEE AND FUNDING FOR A NEW GRANTEE WAS REMITTED IN FY25. SPECIALTY PHARMACY GRANT FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE:ADMINISTERED BY THE FOUNDATION IN CLOSE CONSULTATION WITH THE ASHP SECTION OF SPECIALTY PHARMACY PRACTITIONERS, AND SUPPORTED BY OMNICELL, INC., THE GRANT FUNDED PROJECTS FOCUSED ON SPECIALTY PHARMACY FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE. THE GRANTS WERE AWARDED IN FY24. THE COHORT ENGAGED WITH A COACH AND FACULTY ON LIVE CALLS TO DISCUSS TOPICS RELATED TO RESEARCH, DISSEMINATING OUTCOMES, AND IMPLEMENTATION IN FY25. THE GRANTEES PRESENTED AT A SESSION AT THE 2025 MIDYEAR CLINICAL MEETING AND EXHIBITION IN FY26. PHARMACY RESIDENT PRACTICE-BASED RESEARCH GRANT PROGRAM: THE PHARMACY RESIDENT RESEARCH GRANT SUPPORTS QUALITY HEALTH SERVICE RESEARCH FOCUSED ON PRACTICE ADVANCEMENT CONDUCTED BY RESIDENTS IN ASHP-ACCREDITED PHARMACY RESIDENCY PROGRAMS. THIS GRANT PROGRAM IS FUNDED THROUGH THE ALMQUIST ENDOWMENT. THE EXTERNAL REVIEW PANEL RECOMMENDED FUNDING UP TO $5,000 EACH FOR SIX (6) GRANT PROJECTS. ONE GRANT WAS PARTIALLY FUNDED THROUGH THE DWIGHT R. TOUSIGNAUT MEMORIAL FUND. OPTIMIZING TECHNOLOGY SOLUTIONS INNOVATION GRANT: CREATED IN PARTNERSHIP WITH THE ASHP INNOVATION CENTER AND SUPPORTED BY A GENEROUS DONATION FROM OMNICELL, INC. TO THE ASHP FOUNDATION, THIS PROGRAM FUNDS PROJECTS THAT DEMONSTRATE THE IMPACT OF OPTIMIZING HEALTH INFORMATION TECHNOLOGY AND DIGITAL TRANSFORMATION THAT ENHANCE SAFE AND EFFECTIVE USE OF MEDICATIONS. TWO GRANTEES WERE AWARDED $30,000 IN FY25. RESEARCH ADVISORY COUNCIL:IN FY25, DR. RASHID MOSAVIN SERVED AS THE CHAIR AND DR. RANDALL KNOEBEL SERVED AS THE VICE CHAIR OF THE RESEARCH ADVISORY COUNCIL (RAC) FOR THE TERM. THREE MEMBERS WERE REAPPOINTED AND TWO MEMBERS COMPLETED THEIR SERVICE IN MAY 2024. NO NEW MEMBERS WERE APPOINTED FOR THIS TERM. THE RAC CONVENED VIRTUALLY THROUGHOUT THE YEAR AND LED A VIRTUAL NETWORKING SESSION IN SUMMER 2024. THE RAC PARTICIPATED IN AN IN-PERSON MEETING AT ASHP HEADQUARTERS IN SEPTEMBER 2024, TO ALIGN WITH ASHP'S POLICY WEEK ACTIVITIES. THERE WAS ONE RESEARCH PODCAST HIGHLIGHTING THE SUSTAINED CONTRIBUTIONS RECIPIENT LAUNCHED AND A RESEARCH ROUNDTABLE WAS HELD DURING THE ASHP MIDYEAR CLINICAL MEETING IN DECEMBER 2024. PHARMACY FORECAST REPORT 2025: THE 2025 PHARMACY FORECAST REPORT WAS SUPPORTED BY A GRANT FROM OMNICELL, INC., TO THE ASHP FOUNDATION'S DAVID A. ZILZ LEADERS FOR THE FUTURE FUND AND WAS PUBLISHED IN AJHP IN THE JANUARY 15, 2025 ISSUE. THE DISTRIBUTION OF THE FORECAST REPORT IN AJHP ENSURED THAT IT WAS MADE AVAILABLE TO ALL 60,000 ASHP MEMBERS. IT WAS PUBLISHED ELECTRONICALLY IN DECEMBER 2024 AND PREVIEWED DURING AN EDUCATIONAL SESSION AT THE 2024 ASHP MIDYEAR CLINICAL MEETING. THE REPORT GENERATED AUTHORITATIVE, ACTIONABLE STRATEGIC RECOMMENDATIONS TO ENHANCE THE EFFECTIVENESS OF LEADERS IN HOSPITAL AND HEALTH-SYSTEM PHARMACY. PHARMACY IMPACT RESEARCH:THE ASHP FOUNDATION PROVIDED A GRANT TO ASHP TO SUPPORT THE CONSENSUS PROCESS AND DISSEMINATION OF RESULTS FOR THE MEASURE FOR IMPACT: DEMONSTRATING VALUE OF PHARMACY SERVICES PROJECT. USING VALIDATED CONSENSUS BUILDING METHODOLOGY, THE INITIATIVE'S GOAL IS TO ENGAGE SUBJECT MATTER EXPERTS FROM A VARIETY OF PRACTICE SETTINGS TO IDENTIFY STANDARD MEASURES FOR PHARMACY PRACTICE. MEASURES WILL BE SELECTED FOR THE FOLLOWING DOMAINS: (1) MEDICATION USE AND SAFETY, (2) PATIENT CARE AND QUALITY, (3) OPERATIONS, AUTOMATION AND TECHNOLOGY, (4) WORKFORCE AND PEOPLE, AND (5) FINANCIAL MANAGEMENT. PART OF THE GRANT WAS PROVIDED IN FY25 WITH THE REMAINING FUNDS SCHEDULED TO BE REMITTED IN FY26 WITH WORK CONTINUING THROUGHOUT THE YEAR.Expenses $835,278 · grants $297,889
- THE ASHP FOUNDATION CORPORATE PARTNERS PROGRAM IS A STRATEGIC PARTNERSHIP BETWEEN THE ASHP FOUNDATION, ASHP, AND CORPORATIONS WHICH PROMOTES MEDICATION SAFETY AND IMPROVEMENTS IN PATIENT CARE. THE PROGRAM OFFERS A ROBUST MENU OF SPONSORSHIP LEVELS AND BENEFITS FOR COMPANIES, FOCUSED ON COLLABORATION, RECOGNITION, AND INFORMATIONAL OPPORTUNITIES. THERE ARE FOUR SPONSORSHIP LEVELS AND A-LA-CARTE OPPORTUNITIES TO BETTER MEET BUSINESS OBJECTIVES. CORPORATE PARTNERS PROGRAM SPONSORSHIP IS ON AN ANNUAL BASIS. WITH THE GENEROUS SUPPORT OF CORPORATE PARTNERS, THE ASHP FOUNDATION INVESTS IN RESEARCH, AWARDS, EDUCATION, AND LEADERSHIP DEVELOPMENT THAT ADVANCES THE PHARMACY PROFESSION AND ENSURES THE SAFE, EFFECTIVE, AND OPTIMAL USE OF MEDICATIONS.
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in May, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | May 31, 2026 | October 15, 2026 | Not on file |
| 2024 | May 31, 2025 | October 15, 2025 | 990 on file |
| 2023 | May 31, 2024 | October 15, 2024 | 990 on file |
IRS record
- EIN
- 23-7033369
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1999
- Accounting year ends
- May
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Religion-related (X99)
- Assets (IRS master file)
- $14,275,101
- Income (IRS master file)
- $4,445,044
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | May 2025 | $3,585,475 | $3,245,282 | $14,275,101 | XML |
| 990 | May 2024 | $2,985,544 | $3,370,175 | $13,572,570 | XML |
| 990 | May 2023 | $3,278,745 | $2,993,667 | $12,995,656 | XML |
| 990 | May 2022 | $3,253,731 | $2,747,285 | $13,385,213 | IRS |
| 990 | May 2021 | – | – | – | IRS |
| 990 | May 2020 | – | – | – | IRS |
| 990 | May 2019 | – | – | – | IRS |
| 990 | May 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 23-7033369).
Questions about AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION
- What is the EIN of AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION?
- The employer identification number (EIN) of AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION is 23-7033369.
- Is AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1999.
- Are donations to AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION due?
- The return for tax year 2025 (the year ending May 31, 2026) is due October 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended May 2025.
- Who is the principal officer of AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION?
- The 990 for the year ended May 31, 2025 names KELLY MCCORMICK-SULLIVAN.
- Who are the officers and directors of AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION?
- The 990 for the year ended May 31, 2025 lists 19 people; 5 received compensation from the organization.
- How much revenue does AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION have?
- On its 990 for the year ended May 31, 2025 it reported revenue of $3,585,475, expenses of $3,245,282 and total assets of $14,275,101 at year end.
Other nonprofits in BETHESDA
- FRIENDS OF THE TZEMACH TZEDEK SYNAGOGUE INC EIN 87-2273103 · last filed 990 for 2023
- THE DEN COLLECTIVE INC EIN 81-2724200 · last filed 990 for 2025
- BENEVOLENT BUDDHIST TEMPLE INC EIN 26-4303387 · last filed 990 for 2025
- FRIENDS OF JCC BUDAPEST INC EIN 93-2155245 · last filed 990 for 2025
- BETHESDA MISSION ASSOCIATES INC EIN 54-2133240 · last filed 990-PF for 2024
- NEXT WAVE MUSLIM INITIATIVE INC EIN 45-2984068 · last filed 990 for 2024
- TSERHA TSION MAHIBERE BALEWOLD INC EIN 26-4166848 · last filed 990 for 2019
- BRIGGS CENTER FOR FAITH AND ACTION EIN 53-0230056 · last filed 990 for 2025